Nokia Oyj stock slides in Helsinki as Kepler upgrade bounce fades ahead of Jan. 29 results

Nokia Oyj stock slides in Helsinki as Kepler upgrade bounce fades ahead of Jan. 29 results

Nokia shares fell about 4% to 5.534 euros in Helsinki on Thursday, reversing part of Wednesday’s gain after Kepler Cheuvreux upgraded the stock to “buy” and raised its target price to 6.60 euros. Another broker maintained a bearish stance. Investors await Nokia’s Jan. 29 earnings for updates on margins and cash flow. In U.S. trading, Nokia’s ADRs dropped 3.3% to $6.57.
8 January 2026
NASA may bring ISS Crew-11 home early after astronaut medical concern scrubs spacewalk

NASA may bring ISS Crew-11 home early after astronaut medical concern scrubs spacewalk

NASA is considering an early return of the SpaceX Crew-11 team from the International Space Station after a crew member developed a medical issue, forcing cancellation of a planned spacewalk. The astronaut is stable, but NASA has not identified the individual or disclosed details. Crew-11 arrived in August and includes astronauts from the U.S., Japan, and Russia. NASA will provide another update within 24 hours.
8 January 2026
Nvidia stock rises on China H200 upfront-payment squeeze as traders eye approvals and earnings

Nvidia stock rises on China H200 upfront-payment squeeze as traders eye approvals and earnings

Nvidia shares rose about 1% early Thursday after Reuters reported the company now requires full upfront payment from Chinese buyers of its H200 AI chips. The move comes as Nvidia awaits export licenses amid strong demand from China. Investors are watching for new orders and the company’s Feb. 25 results. Separately, Nvidia executive Ajay K. Puri filed to sell up to 200,000 shares.
Air China cashes out $170 million Cathay Pacific stake as a Qatar buyback reshapes the shareholder map

Air China cashes out $170 million Cathay Pacific stake as a Qatar buyback reshapes the shareholder map

Air China is selling 108.1 million shares in Cathay Pacific for HK$1.32 billion ($170 million), cutting its stake to just under 30% after a planned buyback. Swire Pacific’s holding will rise to about 47.65%. The sale price is HK$12.22 per share, with completion expected by Jan. 8. Filings show the deal depends on takeover-rule waivers and regulatory approvals.
8 January 2026
Dow Futures Slip After Jobless Claims; Trump’s $1.5 Trillion Pentagon Talk Lifts Defense Stocks

Dow Futures Slip After Jobless Claims; Trump’s $1.5 Trillion Pentagon Talk Lifts Defense Stocks

U.S. stock index futures slipped before Thursday’s open, with the Dow, Nasdaq 100, and S&P 500 down up to 0.4% in premarket trading. Defense shares surged after Donald Trump proposed a $1.5 trillion 2027 military budget. Apple and Tesla fell, while Alphabet rose nearly 1% after overtaking Apple in market value. Weekly jobless claims increased by 8,000 to 208,000.
Ondas stock slips after SEC filing tees up more shares for resale in Sentry deal

Ondas stock slips after SEC filing tees up more shares for resale in Sentry deal

Ondas Holdings shares fell about 5% to $12.18 in early trading Thursday after the company filed to register 1.67 million shares for resale tied to its Sentry CS acquisition. The shares were issued as part of a $2.5 million cash-and-stock payment on Jan. 8. Ondas will not receive proceeds from the resale. Investors are watching for updates at a Needham conference Jan. 14 and an investor day Jan. 16.
8 January 2026
Omeros stock rises in premarket after $36,000-a-vial Yartemlea price is set

Omeros stock rises in premarket after $36,000-a-vial Yartemlea price is set

Omeros Corp shares rose about 4% to $14.09 premarket after setting a $36,000 price for each vial of newly approved Yartemlea, used to treat TA-TMA in transplant patients. The company began its U.S. launch Jan. 2 and reported $171.5 million in cash at year-end. Shares jumped 6.6% in after-hours trading Wednesday. Analysts raised price targets following the announcement.
Intel stock jumps in premarket as 18A ramp talk keeps the turnaround trade hot

Intel stock jumps in premarket as 18A ramp talk keeps the turnaround trade hot

Intel shares jumped 6.4% to $42.63 in premarket trading Thursday after executives at CES said the company met its 18A chip production target for 2025 and began ramping Core Ultra Series 3. The company showed new “AI PC” laptops from 15 makers, with pre-orders starting this week. AMD and TSMC U.S. shares fell about 2% premarket, while Nvidia gained 1%. Intel will report Q4 and full-year results on Jan. 22.
American Airlines stock (AAL) slips premarket as free Wi‑Fi plan lands and earnings near

American Airlines stock (AAL) slips premarket as free Wi‑Fi plan lands and earnings near

American Airlines shares slipped 0.2% to $15.96 premarket Thursday after announcing free, AT&T-sponsored in-flight Wi‑Fi for AAdvantage loyalty members. The move follows similar offerings from Delta and United. Investors await late-January earnings for signs on demand and costs. UBS raised its price target on the stock to $21.
Nvidia stock rises in premarket as tough China payment terms put H200 demand back in focus

Nvidia stock rises in premarket as tough China payment terms put H200 demand back in focus

Nvidia is demanding full upfront payment and barring cancellations for H200 chip orders in China, as export approvals remain uncertain. NVDA shares rose 0.5% to $190.05 premarket. Chinese firms have ordered over 2 million H200 chips, but Nvidia holds only about 700,000 units in inventory. Beijing has asked some tech firms to pause orders while it considers requiring purchases of domestic AI chips.
8 January 2026
Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Immuneering shares surged 24% to $8.33 premarket after reporting 64% overall 12-month survival in a 34-patient Phase 2a pancreatic cancer trial. The company compared this to a 35% benchmark from standard chemotherapy. Median progression-free survival reached 8.5 months. Immuneering plans a larger data update and to start a Phase 3 trial in mid-2026.
Eli Lilly stock pops in premarket on $1.2 billion Ventyx deal — what traders watch next

Eli Lilly stock pops in premarket on $1.2 billion Ventyx deal — what traders watch next

Eli Lilly shares rose 4.1% premarket to $1,108.09 after the company agreed to buy Ventyx Biosciences for $1.2 billion in cash. The deal, expected to close in the first half of 2026, adds oral inflammation drugs to Lilly’s pipeline. Lilly will pay $14 per Ventyx share, a 62% premium to its recent average. Investors are watching for details on pipeline progress and spending ahead of Lilly’s next earnings call.
8 January 2026

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop